Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Influenza
Studies from GlaxoSmithKline add new findings in the area of influenza
March 12th, 2008
According to recent research from Munich, Germany, "Children previously unvaccinated against influenza are recommended to receive two doses of trivalent inactivated influenza vaccine (TIV). This study assessed the age limit for a second dose of TIV in previously unvaccinated children." "Two hundred and twenty-four children were immunized with TIV (Influsplit SSW (TM)/Fluarix (TM); GlaxoSmithKline Biologicals). Subjects aged 6-9 years (n = 110) received two doses of TIV 4 weeks apart; those aged 10-13 years (n = 114) received a single dose. Serum haemagglutination inhibiting (HI) antibody titers were evaluated before and after each vaccination. CHMP criteria for HI...
Source: Vaccine Weekly (2008-03-12)
|
